Clinical Trials Browser

Phase 2 × OTHER × Hypereosinophilic Syndrome × Clear all

Leukemia, Mastocytosis, Myelodysplastic Syndromes, Polycythemia Vera, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hypereosinophilic Syndrome, Primary Myelofibrosis

NCT00483067 2012-08-02

2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)

Phase 2 Completed

13 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Hypereosinophilic Syndrome

Clinical Trials

Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)

2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)